Literature DB >> 26454897

Why admixture matters in genetically-guided therapy: missed targets in the COAG and EU-PACT trials.

Jorge Duconge, Carmen L Cadilla, Richard L Seip, Gualberto Ruaño.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26454897      PMCID： PMC4770896     

Source DB:  PubMed          Journal:  P R Health Sci J        ISSN： 0738-0658            Impact factor:   0.705


× No keyword cloud information.
  10 in total

1.  CYP2C9 and VKORC1 genotypes in Puerto Ricans: A case for admixture-matching in clinical pharmacogenetic studies.

Authors:  David Villagra; Jorge Duconge; Andreas Windemuth; Carmen L Cadilla; Mohan Kocherla; Krystyna Gorowski; Kali Bogaard; Jessica Y Renta; Irelys A Cruz; Sara Mirabal; Richard L Seip; Gualberto Ruaño
Journal:  Clin Chim Acta       Date:  2010-05-19       Impact factor: 3.786

2.  A pharmacogenetic versus a clinical algorithm for warfarin dosing.

Authors:  Stephen E Kimmel; Benjamin French; Scott E Kasner; Julie A Johnson; Jeffrey L Anderson; Brian F Gage; Yves D Rosenberg; Charles S Eby; Rosemary A Madigan; Robert B McBane; Sherif Z Abdel-Rahman; Scott M Stevens; Steven Yale; Emile R Mohler; Margaret C Fang; Vinay Shah; Richard B Horenstein; Nita A Limdi; James A S Muldowney; Jaspal Gujral; Patrice Delafontaine; Robert J Desnick; Thomas L Ortel; Henny H Billett; Robert C Pendleton; Nancy L Geller; Jonathan L Halperin; Samuel Z Goldhaber; Michael D Caldwell; Robert M Califf; Jonas H Ellenberg
Journal:  N Engl J Med       Date:  2013-11-19       Impact factor: 91.245

3.  Implications of correlations between skin color and genetic ancestry for biomedical research.

Authors:  E J Parra; R A Kittles; M D Shriver
Journal:  Nat Genet       Date:  2004-11       Impact factor: 38.330

Review 4.  Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing.

Authors:  J A Johnson; L Gong; M Whirl-Carrillo; B F Gage; S A Scott; C M Stein; J L Anderson; S E Kimmel; M T M Lee; M Pirmohamed; M Wadelius; T E Klein; R B Altman
Journal:  Clin Pharmacol Ther       Date:  2011-09-07       Impact factor: 6.875

5.  The Emerging Role of Admixture in the Pharmacogenetics of Puerto Rican Hispanics.

Authors:  Jorge Duconge; Gualberto Ruaño
Journal:  J Pharmacogenomics Pharmacoproteomics       Date:  2010-10-04

6.  Effect of NQO1 and CYP4F2 genotypes on warfarin dose requirements in Hispanic-Americans and African-Americans.

Authors:  Adam Bress; Shitalben R Patel; Minoli A Perera; Richard T Campbell; Rick A Kittles; Larisa H Cavallari
Journal:  Pharmacogenomics       Date:  2012-12       Impact factor: 2.533

7.  Physiogenomic analysis of the Puerto Rican population.

Authors:  Gualberto Ruaño; Jorge Duconge; Andreas Windemuth; Carmen L Cadilla; Mohan Kocherla; David Villagra; Jessica Renta; Theodore Holford; Pedro J Santiago-Borrero
Journal:  Pharmacogenomics       Date:  2009-04       Impact factor: 2.533

8.  A randomized trial of genotype-guided dosing of warfarin.

Authors:  Munir Pirmohamed; Girvan Burnside; Niclas Eriksson; Andrea L Jorgensen; Cheng Hock Toh; Toby Nicholson; Patrick Kesteven; Christina Christersson; Bengt Wahlström; Christina Stafberg; J Eunice Zhang; Julian B Leathart; Hugo Kohnke; Anke H Maitland-van der Zee; Paula R Williamson; Ann K Daly; Peter Avery; Farhad Kamali; Mia Wadelius
Journal:  N Engl J Med       Date:  2013-11-19       Impact factor: 91.245

9.  History shaped the geographic distribution of genomic admixture on the island of Puerto Rico.

Authors:  Marc Via; Christopher R Gignoux; Lindsey A Roth; Laura Fejerman; Joshua Galanter; Shweta Choudhry; Gladys Toro-Labrador; Jorge Viera-Vera; Taras K Oleksyk; Kenneth Beckman; Elad Ziv; Neil Risch; Esteban González Burchard; Juan Carlos Martínez-Cruzado
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240

10.  Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study.

Authors:  Minoli A Perera; Larisa H Cavallari; Nita A Limdi; Eric R Gamazon; Anuar Konkashbaev; Roxana Daneshjou; Anna Pluzhnikov; Dana C Crawford; Jelai Wang; Nianjun Liu; Nicholas Tatonetti; Stephane Bourgeois; Harumi Takahashi; Yukiko Bradford; Benjamin M Burkley; Robert J Desnick; Jonathan L Halperin; Sherief I Khalifa; Taimour Y Langaee; Steven A Lubitz; Edith A Nutescu; Matthew Oetjens; Mohamed H Shahin; Shitalben R Patel; Hersh Sagreiya; Matthew Tector; Karen E Weck; Mark J Rieder; Stuart A Scott; Alan H B Wu; James K Burmester; Mia Wadelius; Panos Deloukas; Michael J Wagner; Taisei Mushiroda; Michiaki Kubo; Dan M Roden; Nancy J Cox; Russ B Altman; Teri E Klein; Yusuke Nakamura; Julie A Johnson
Journal:  Lancet       Date:  2013-06-05       Impact factor: 79.321
  10 in total
  4 in total

1.  Leaving some behind: the growing gap in precision medicine for minority populations.

Authors:  Minoli Perera
Journal:  Expert Rev Precis Med Drug Dev       Date:  2018-10-04

Review 2.  Implementing Precision Medicine: The Ethical Challenges.

Authors:  Diane M Korngiebel; Kenneth E Thummel; Wylie Burke
Journal:  Trends Pharmacol Sci       Date:  2016-12-07       Impact factor: 14.819

3.  Potential of a Pharmacogenetic-Guided Algorithm to Predict Optimal Warfarin Dosing in a High-Risk Hispanic Patient: Role of a Novel NQO1*2 Polymorphism.

Authors:  Dagmar F Hernandez-Suarez; Karla Claudio-Campos; Javier E Mirabal-Arroyo; Bianca A Torres-Hernández; Angel López-Candales; Kyle Melin; Jorge Duconge
Journal:  J Investig Med High Impact Case Rep       Date:  2016-12-01

4.  A Novel Admixture-Based Pharmacogenetic Approach to Refine Warfarin Dosing in Caribbean Hispanics.

Authors:  Jorge Duconge; Alga S Ramos; Karla Claudio-Campos; Giselle Rivera-Miranda; Luis Bermúdez-Bosch; Jessicca Y Renta; Carmen L Cadilla; Iadelisse Cruz; Juan F Feliu; Cunegundo Vergara; Gualberto Ruaño
Journal:  PLoS One       Date:  2016-01-08       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.